Evidence map›Paper›PMID 18677446›Full record

ReviewJournal of molecular neuroscience : MN2008

The role of vasoactive intestinal polypeptide and pituitary adenylate cyclase-activating polypeptide in the neural pathways controlling the lower urinary tract.

Mitsuharu Yoshiyama, William C de Groat

Open access · greenAbstract readReview
In one paragraph

Review in Journal of molecular neuroscience : MN, 2008. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers.

0numbers the graph read from it
0cells of the map it votes in
23citing papers in PubMed
2.0field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

23 citing papers in PubMed, 44 citations in OpenAlex.

  1. Neuropeptides and the Autonomic Nervous System in Prader-Willi Syndrome.International journal of molecular sciences · 2025
    Review
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. The Role of the Mucosa in Normal and Abnormal Bladder Function.Basic & clinical pharmacology & toxicology · 2016
    Review
  10. Article
  11. Review
  12. Neural control of the lower urinary tract.Comprehensive Physiology · 2015
    Review
  13. Article
  14. Remote control of renal physiology by the intestinal neuropeptide pigment-dispersing factor in Drosophila.Proceedings of the National Academy of Sciences of the United States of America · 2012
    Article
  15. Review
  16. Article
  17. Neuropeptides in lower urinary tract function.Handbook of experimental pharmacology · 2011
    Review
  18. Mechanisms of action of sacral neuromodulation.International urogynecology journal · 2010
    Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 2 institutions in 2 countries.

Mitsuharu YoshiyamaYamanashi Rehabilitation Hospital, Fuefuki, Yamanashi, 406-0004, Japan.
William C de Groat
University of Pittsburgh · USUniversity of Yamanashi · JP

Funding

AFFERENT MECHANISMS UNDERLYING BLADDER PAINR37DK049430 · NIDDK · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI DEGROAT, WILLIAM C · 2000 to 2009
$3.0M
Neuroplasticity of Urinary Tract Disorders after SCIR01DK077783 · NIDDK · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI DEGROAT, WILLIAM C · 2007 to 2010
$1.2M
AFFERENT MECHANISMS UNDERLYING BLADDER PAINR01DK049430 · NIDDK · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI DEGROAT, WILLIAM C · 1994 to 1998
–
NIDDK NIH HHS DK 49430NIDDK NIH HHS DK 77783NIDDK NIH HHS R01 DK049430NIDDK NIH HHS R01 DK077783NIDDK NIH HHS R37 DK049430
6 · The paper itself

Abstract

Vasoactive intestinal polypeptide (VIP) and pituitary adenylate cyclase-activating polypeptide (PACAP) are expressed in the neural pathways regulating the lower urinary tract. VIP-immunoreactivity (IR) is present in afferent and autonomic efferent neurons innervating the bladder and urethra, whereas PACAP-IR is present primarily in afferent neurons. Exogenously applied VIP relaxes bladder and urethral smooth muscle and excites parasympathetic neurons in bladder ganglia. PACAP relaxes bladder and urethral smooth muscle in some species (pig) but excites the smooth muscle in other species (mouse). Intrathecal administration of VIP in cats with an intact spinal cord suppresses reflex bladder activity, but intrathecal administration of VIP or PACAP in rats enhances bladder activity and suppresses urethral sphincter activity. PACAP has presynaptic facilitatory effects and direct excitatory effects on lumbosacral parasympathetic preganglionic neurons. Chronic spinal cord transection produces an expansion of VIP-IR (cats) and PACAP-IR (rats) in primary afferent axons in the lumbosacral spinal cord and unmasks spinal excitatory effects of VIP on bladder reflexes in cats. Intrathecal administration of PACAP6-38, a PAC1 receptor antagonist, reduces bladder hyperactivity in chronic spinal-cord-injured rats. These observations raise the possibility that VIP or PACAP have a role in the control of normal or abnormal voiding.

Indexed as

AnimalsMuscle, SmoothNeural PathwaysPituitary Adenylate Cyclase-Activating PolypeptideReceptors, Pituitary Adenylate Cyclase-Activating Polypeptide, Type IReflexSpinal CordSpinal Cord InjuriesUrinary TractVasoactive Intestinal PeptidePituitary Adenylate Cyclase-Activating PolypeptideReceptors, Pituitary Adenylate Cyclase-Activating Polypeptide, Type IVasoactive Intestinal Peptide

Identifiers

PMID18677446
PMCPMC3111967
OpenAlexW2088345641

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.